Overview of Radiation Therapy in the Management of Localized and Metastatic Prostate Cancer.

Autor: Mattes MD; Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ, 08901, USA. mattesmd@cinj.rutgers.edu.
Jazyk: angličtina
Zdroj: Current urology reports [Curr Urol Rep] 2024 Aug; Vol. 25 (8), pp. 181-192. Date of Electronic Publication: 2024 Jun 11.
DOI: 10.1007/s11934-024-01217-5
Abstrakt: Purpose of Review: The goal is to describe the evolution of radiation therapy (RT) utilization in the management of localized and metastatic prostate cancer.
Recent Findings: Long term data for a variety of hypofractionated definitive RT dose-fractionation schemes has matured, allowing patients and providers many standard-of-care options to choose from. Post-prostatectomy, adjuvant RT has largely been replaced by an early salvage approach. Multiparametric MRI and PSMA PET have enabled increasingly targeted RT delivery to the prostate and oligometastatic tumors. Areas of active investigation include determining the value of proton beam therapy and perirectal spacers, and optimally incorporate genomic tumor profiling and next generation hormonal therapies with RT in the curative setting. The use of radiation therapy to treat prostate cancer is rapidly evolving. In the coming years, there will be continued improvements in a variety of areas to enhance the value of RT in multidisciplinary prostate cancer management.
(© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
Databáze: MEDLINE
Externí odkaz: